1255 — TATA Health International Holdings Income Statement
0.000.00%
Last trade - 00:00Consumer CyclicalsHighly SpeculativeMicro Cap
Annual income statement for TATA Health International Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | PRESS | PRESS | PRESS |
| Standards: | HKAS | HKAS | — | — | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 155 | 161 | 145 | 208 | 124 |
| Cost of Revenue | |||||
| Gross Profit | 34.3 | 105 | 114 | 151 | 84.9 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 325 | 227 | 139 | 241 | 188 |
| Operating Profit | -170 | -65.8 | 5.39 | -33.5 | -63.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -173 | -69.1 | 2.5 | -35.4 | -68 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -173 | -70.5 | 1.6 | -36 | -68.3 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -152 | -60.8 | 8.05 | -32.3 | -68.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -152 | -60.8 | 8.05 | -32.3 | -68.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.641 | -0.251 | 0.032 | -0.114 | -0.235 |